Atlas FDA

TREO® Abdominal Stent-Graft System

FDA premarket approval P190015 · decided 2020-05-04

Approval details

PMA number
P190015
Trade name
TREO® Abdominal Stent-Graft System
Generic name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Applicant
Bolton Medical, Inc.
Date received
2019-06-03
Decision date
2020-05-04
Days to decision
336 days
Decision code
APPR
Product code
MIH
Advisory committee
Cardiovascular
Expedited review
No
Location
Sunrise, FL
Statement
Approval for TREO® Abdominal Stent-Graft System. This device is indicated for use in the endovascular treatment of patients with infrarenal abdominal aortic and aorto-iliac aneurysms with the following characteristics:1. Adequate iliac or femoral access compatible with the required delivery systems and accessories;2. Proximal aortic landing zone with: 2a. Infrarenal landing neck length of >= 15mm; 2b. Aortic neck diameters >= 17 mm and <= 32 mm; 2c. Suprarenal neck angle of <= 45 degrees; 2d. In

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
BOLTON PTA CATHETER (K021996)Bolton Medical, Inc.2002-08-23